Tokyo Tape
Sign in
← CellSeed

Quarterly report · Q3

7776.TEDINET S100S7NI
Period2023-01-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥119m2023-01-01 → 2023-09-30StandaloneNet sales
Revenue¥126m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥88m2022-01-01 → 2022-09-30StandaloneNet sales
Operating income−¥577m2023-01-01 → 2023-09-30StandaloneOperating income
Operating income−¥564m2022-01-01 → 2022-09-30StandaloneOperating income
Ordinary income−¥587m2023-01-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥754m2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥571m2022-01-01 → 2022-09-30StandaloneOrdinary income
Profit before tax−¥584m2023-01-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax−¥572m2022-01-01 → 2022-09-30StandaloneIncome before income taxes
Net income−¥585m2023-01-01 → 2023-09-30StandaloneProfit loss
Net income−¥760m2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥574m2022-01-01 → 2022-09-30StandaloneProfit loss
Total assets¥2.6bnat 2023-09-30StandaloneAssets
Total assets¥1.5bnat 2022-12-31StandaloneAssets
Total assets¥1.5bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥390mat 2023-09-30StandaloneLiabilities
Total liabilities¥366mat 2022-12-31StandaloneLiabilities
Net assets / equity¥2.3bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.1bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥2.2bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2022-12-31StandaloneCash and deposits
EPS (basic)¥-20.952023-01-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-7.622023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.382022-01-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-9.82022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio84.4%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.3%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued30,889,419at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued24,422,619at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued22,159,419at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-09-30−¥147m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2023-01-01 → 2023-09-30¥8m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2023-01-01 → 2023-09-30¥8m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2023-01-01 → 2023-09-30−¥394m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2023-01-01 → 2023-09-30¥111m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2023-01-01 → 2023-09-30¥111m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2023-01-01 → 2023-09-30−¥36m
—segment totalrevenue2023-01-01 → 2023-09-30¥119m
—segment totalrevenue external2023-01-01 → 2023-09-30¥119m
—segment totalsegment profit2023-01-01 → 2023-09-30−¥430m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥147m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2022-01-01 → 2022-09-30¥7m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2022-01-01 → 2022-09-30¥7m
jpcrp040300-q3r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-09-30−¥347m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2022-01-01 → 2022-09-30¥81m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2022-01-01 → 2022-09-30¥81m
jpcrp040300-q3r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2022-01-01 → 2022-09-30−¥70m
—segment totalrevenue2022-01-01 → 2022-09-30¥88m
—segment totalrevenue external2022-01-01 → 2022-09-30¥88m
—segment totalsegment profit2022-01-01 → 2022-09-30−¥418m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 307
ItemContextValueUnit
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember100
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember28374400
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember283744
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember10919
Number of shares issued shares voting rightsCurrentQuarterInstant28385419
Number of voting rights issued shares voting rightsCurrentQuarterInstant283744
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member100
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0000
Number of shares held in own name treasury shares etcCurrentQuarterInstant100
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0000
Cash and depositsPrior1YearInstant_NonConsolidatedMember1072210000JPY
Cash and depositsCurrentQuarterInstant_NonConsolidatedMember2199882000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember25775000JPY
Accounts receivable tradeCurrentQuarterInstant_NonConsolidatedMember47971000JPY
Merchandise and finished goodsPrior1YearInstant_NonConsolidatedMember19757000JPY
Merchandise and finished goodsCurrentQuarterInstant_NonConsolidatedMember18472000JPY
Work in processPrior1YearInstant_NonConsolidatedMember836000JPY
Work in processCurrentQuarterInstant_NonConsolidatedMember7784000JPY
Raw materials and suppliesPrior1YearInstant_NonConsolidatedMember35573000JPY
Raw materials and suppliesCurrentQuarterInstant_NonConsolidatedMember29288000JPY
Other caPrior1YearInstant_NonConsolidatedMember77783000JPY
Other caCurrentQuarterInstant_NonConsolidatedMember73214000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember1231937000JPY
Current assetsCurrentQuarterInstant_NonConsolidatedMember2376614000JPY
Property plant and equipmentPrior1YearInstant_NonConsolidatedMember98334000JPY
Property plant and equipmentCurrentQuarterInstant_NonConsolidatedMember93160000JPY
Investments and other assetsPrior1YearInstant_NonConsolidatedMember213648000JPY
Investments and other assetsCurrentQuarterInstant_NonConsolidatedMember170735000JPY
Noncurrent assetsPrior1YearInstant_NonConsolidatedMember311983000JPY
Noncurrent assetsCurrentQuarterInstant_NonConsolidatedMember263895000JPY
AssetsPrior1YearInstant_NonConsolidatedMember1543920000JPY
AssetsCurrentQuarterInstant_NonConsolidatedMember2640509000JPY
Accounts payable tradePrior1YearInstant_NonConsolidatedMember394000JPY
Accounts payable tradeCurrentQuarterInstant_NonConsolidatedMember7928000JPY
Current portion of long term loans payablePrior1YearInstant_NonConsolidatedMember7500000JPY
Current portion of long term loans payableCurrentQuarterInstant_NonConsolidatedMember8125000JPY
Provision for bonusesPrior1YearInstant_NonConsolidatedMember3384000JPY
Provision for bonusesCurrentQuarterInstant_NonConsolidatedMember15779000JPY
Other clPrior1YearInstant_NonConsolidatedMember169416000JPY
Other clCurrentQuarterInstant_NonConsolidatedMember173912000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember180695000JPY
Current liabilitiesCurrentQuarterInstant_NonConsolidatedMember205745000JPY
Long term loans payablePrior1YearInstant_NonConsolidatedMember151250000JPY
Long term loans payableCurrentQuarterInstant_NonConsolidatedMember145000000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember33637000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass